These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11326654

  • 1. Prostate-specific antigen (PSA) in the monitoring of prostate cancer after radical prostatectomy and external beam radiation.
    Schaefer U, Witt F, Schueller P, Micke O, Willich N.
    Anticancer Res; 2000; 20(6D):4989-92. PubMed ID: 11326654
    [Abstract] [Full Text] [Related]

  • 2. Prostate-specific antigen (PSA) and radiotherapy in locally confined prostate cancer.
    Schaefer U, Micke O, Willich N.
    Anticancer Res; 1999; 19(4A):2645-8. PubMed ID: 10470211
    [Abstract] [Full Text] [Related]

  • 3. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 4. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB, Zerbib M, Mejean A, Rouach Y, Debre B, Peyromaure M.
    Can J Urol; 2009 Oct 01; 16(5):4813-9. PubMed ID: 19796456
    [Abstract] [Full Text] [Related]

  • 5. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.
    Soergel TM, Koch MO, Foster RS, Bihrle R, Wahle G, Gardner T, Jung SH.
    J Urol; 2001 Dec 01; 166(6):2198-201. PubMed ID: 11696735
    [Abstract] [Full Text] [Related]

  • 6. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
    Cozzarini C, Montorsi F, Fiorino C, Alongi F, Bolognesi A, Da Pozzo LF, Guazzoni G, Freschi M, Roscigno M, Scattoni V, Rigatti P, Di Muzio N.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):966-74. PubMed ID: 19619960
    [Abstract] [Full Text] [Related]

  • 7. Adjuvant radiotherapy in locally confined prostate cancer.
    Schäfer U, Witt F, Micke O, Willich N.
    Anticancer Res; 2003 Nov 15; 23(2A):983-5. PubMed ID: 12820335
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.
    Pruthi RS, Derksen JE, Moore D, Carson CC, Grigson G, Watkins C, Wallen E.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2172-7. PubMed ID: 16609031
    [Abstract] [Full Text] [Related]

  • 9. Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.
    Chung CS, Chen MH, Cullen J, McLeod D, Carroll P, D'Amico AV.
    Urology; 2008 Jan 01; 71(1):136-40. PubMed ID: 18242382
    [Abstract] [Full Text] [Related]

  • 10. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM, Babaian K, Cheung MR, Naya Y, Huang SH, Kuban D, Babaian RJ.
    J Urol; 2003 Nov 01; 170(5):1860-3. PubMed ID: 14532793
    [Abstract] [Full Text] [Related]

  • 11. [PSA and follow-up after treatment of prostate cancer].
    Benchikh El Fegoun A, Villers A, Moreau JL, Richaud P, Rebillard X, Beuzeboc P.
    Prog Urol; 2008 Mar 01; 18(3):137-44. PubMed ID: 18472065
    [Abstract] [Full Text] [Related]

  • 12. Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancer.
    Macdonald OK, Lee RJ, Snow G, Lee CM, Tward JD, Middleton AW, Middleton GW, Sause WT.
    Urology; 2007 Feb 01; 69(2):295-9. PubMed ID: 17320667
    [Abstract] [Full Text] [Related]

  • 13. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
    Koppie TM, Grossfeld GD, Nudell DM, Weinberg VK, Carroll PR.
    J Urol; 2001 Jul 01; 166(1):111-5. PubMed ID: 11435834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The effect of radiotherapy on patients with prostate specific antigen failure after radical prostatectomy].
    Sakata Y, Hasegawa Y, Wakita T, Hayashi N, Fuwa N.
    Hinyokika Kiyo; 2004 Jul 01; 50(7):463-7. PubMed ID: 15334889
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy.
    Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG.
    J Urol; 1996 Nov 01; 156(5):1725-9. PubMed ID: 8863580
    [Abstract] [Full Text] [Related]

  • 18. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ.
    J Urol; 2002 Jul 01; 168(1):110-5. PubMed ID: 12050502
    [Abstract] [Full Text] [Related]

  • 19. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T, Lohm G, Bottke D, Höcht S, Miller K, Siegmann A, Schostak M, Neumann K, Hinkelbein W.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1009-16. PubMed ID: 18963539
    [Abstract] [Full Text] [Related]

  • 20. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.
    Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):993-1002. PubMed ID: 15752878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.